Duane Morris LLPPartner

Daniel Robert Pierce

About Daniel Robert Pierce

Daniel Robert Pierce is a lawyer practicing corporate law, mergers and acquisitions, emerging businesses and 3 other areas of law. Daniel has been licensed for 28 years. Daniel practices at Duane Morris LLP in Boston, MA.

Reviews for Daniel

This lawyer does not have any client reviews on Lawyers.com yet

Write a Review

Services

Areas of Law

  • Corporate Law
  • Investments 1
    • Venture Capital
  • Other 4
    • Mergers and Acquisitions
    • Emerging Businesses
    • Securities Law
    • Intellectual Property Law

Practice Details

  • Firm Information
    Position
    Partner
    Firm Name
    Duane Morris LLP
  • Representative Cases & Transactions
    Cases
    Representative Matters: Represented Certified Collectibles Group, a leading global provider of authentication, grading
    conservation services, in its sale to funds managed by private equity firm Blackstone (NYSE: BX)'s Tactical Opportunities business, which valued the company at more than $500 million.
    Represented Ology Bioservices, Inc., a Florida-based developer
    manufacturer of drugs
    biologics with more than $1.8 billion in government contracts awarded, in its sale to life sciences startup National Resilience
    the acquisition provides Resilience with 300 skilled employees as well as more than 200,000 square feet of manufacturing, office, process development, quality assurance,
    quality control space across locations in Florida, California,
    Maryl
    .
    Represented NGM in its acquisition of the capacitor business manufactured
    sold under the Genteq
    Proline trademarks from Regal Beloit Corporation (RBC).
    Represented Clock Spring Company, Inc., the world's leading manufacturer of composite pipeline repair solutions, in its merger with Neptune Research, LLC to create ClockSpring NRI,
    its acquisition by private equity firm Wind Point Partners. Clock Spring
    NRI are manufacturers of composite materials, valves,
    gaskets used in the transmission pipeline, refinery
    petrochemical, water, utility,
    civil infrastructure industries.
    Represented Framerate, Inc., one of the largest
    fastest growing independent social video networks in esports
    online gaming which generates millions of views per month across Instagram
    Facebook, in its sale to Super League Gaming, Inc., which provides a platform for competitive
    social gameplay experiences
    is exp
    ing its business of running esports events.
    Represented Altamil S.A.
    its affiliates Deported B.V.
    Electro Chango S.A. de C.V., in the sale of Kerbal Space Program, a space simulation game, to Take-Two Interactive Software, an American distributor of video games.
    Represented INNODATA INC. (Nasdaq: INOD) in connection with the acquisition by its MediaMiser subsidiary of the Agility global media contact database
    media monitoring platform from PR Newswire.
    Represented Ology Bioservices Inc. in a purchase from Baxalta, formerly Baxter International's BioScience division, of its Vero cell technology,
    the vaccine production facility in Bohumil, Czech Republic. The Vero platform is a cell-based technology for vaccines production. The principal products acquired are flu vaccines for H5N1, H1N1
    seasonal influenza as well as other investigational vaccine programs including Ross River virus, Chikungunya disease
    West Nile virus.
    Represented J.F. White Contracting Company, a leading heavy/civil contractor in the New Engl
    region, in a series of related transactions, including the redemption of shares held by its ESOP, the sale of 100% of its remaining outst
    ing shares to Dragados Construction USA, Inc. (a subsidiary of publicly-traded ACS Actividades de Construccion y Servicios SA),
    the spin-off of certain assets to a newly formed limited liability company.
    Represented Balchem Corporation (NASDAQ:BCPC) in its acquisition of Performance Chemicals & Ingredients Company (d/b/a SensoryEffects), a privately held supplier of customized food
    beverage ingredient systems, for a purchase price of $567 million in cash.
    Represented Treventis Corporation in securing a $4.4 million Seeding Drug Discovery Award from the Wellcome Trust to continue development of a potentially disease-modifying drug for the treatment of Alzheimer's disease.
    Represented Oligomerix, Inc., a biotechnology start-up focused on developing disease-modifying therapeutics for Alzheimer's
    related neurodegenerative disorders, in connection with a $2.8 million Series B financing, which includes both issuance of new convertible preferred shares
    warrants from both current
    new investors.
    Represented Oligomerix, Inc., a biotechnology start-up focused on developing disease-modifying therapeutics for Alzheimer's
    related neurodegenerative disorders, in connection with a $2.4 million Series A financing provided by angel
    venture capital investors.
    Represented a Mexican manufacturer of electronic component parts in the acquisition of the assets of a manufacturer of electrolytic motor start capacitors.
    Represented a Mexican manufacturer of electronic component parts in the acquisition of the assets of a manufacturer of foil-etching technology.
    Represented Localocracy, LLC, an online platform for citizen engagement in their local communities, in the sale of all of its assets to the HuffingtonPost Media Group.
    Represented a developer
    publisher of consumer
    educational software in the acquisition of several nationally known consumer software titles from an educational
    trade publisher.
    Represented Multimodal Technologies, Inc. in the sale of 100 percent of its outst
    ing equity securities in a reverse triangular merger to Miami Acquisition Corp., a wholly owned subsidiary of Medquist Holdings, Inc. (NASDAQ:MEDH), for an aggregate purchase price of approximately $130 million, including approximately $50 million in cash at closing, approximately $50 million in Medquist common stock at closing,
    approximately $30 million of deferred payments payable in three annual installments.
    Represented Penion Group, LLC, an investment company focusing on small to mid-size business in the Boston area, in its acquisition of the assets of Lynn Manufacturing, Inc.
    its affiliates.
    Represented Nasdaq-traded medical device company in strategic acquisition of privately-held company, including spin-off of unrelated technology
    cross-licensing arrangement.
    Represented defense contractor
    UK subsidiary in sale of assets to large public-company acquirer.
    Represented online career search business in sale of assets.
    Represented a drug-discovery company in the autism field in three rounds of growth-stage financing (Series B, Series B-1
    convertible notes), raising in excess of $15 million.
    Represented a drug-discovery company in the autism field in a $6.5 million Series A round from friends, family
    angels.
    Represented a large India-based venture capital firm in both Series D
    Series E investments a Silicon-Valley IT company.
    Represented biotechnology company in a stock-for-stock merger with publicly-traded acquirer.
    Represented a coal gasification start-up in its seed round (convertible debt)
    Series A round.
    Represented a startup in the food
    beverage industry in seed
    series A rounds.
    Represented a startup in the food
    beverage industry in its sale to a nationally br
    ed premium spirits company.
    Represented boutique investment bank in $35 million investments made by two private equity firms.
    Represented broadcast media company in major corporate restructuring
    several convertible-debt offerings.
    Represented Singapore-based private equity fund in the formation of two U.S.-based feeder funds
    related compliance matters.
    Represented major service provider to nuclear power industry in $150+ million sale to a consortium of private equity firms.
    Represented Waters Corporation in acquisition of Creon Lab Control, AG
    its subsidiaries.
    Represented Waters Corporation in $23 million acquisition of Rheology Business of Rheometric Scientific, Inc.

Experience

  • Bar Admission & Memberships
    Admissions
    1998, Massachusetts
    Memberships

    Professional Activities

    •MassChallenge
    - Mentor, Judge and Speaker
    •MassMEDIC
    •National Association of Corporate Directors
    - Programming Committee, New England Chapter, 2008-2010

  • Education & Certifications
    Law School
    Boston University School of Law
    Class of 1998
    J.D.
    magna cum laude
  • Personal Details & History
    Age
    Born in 1972
    Lowell, Massachusetts, June 14, 1972

Daniel Robert Pierce

Partner at Duane Morris LLP
Not yet reviewed

100 High Street, Suite 2400Boston, MA 02110U.S.A.

Show on map

Lawyers Nearby

Howard L. Levin
Pro
Howard L. Levin
5.0
Corporate Law lawyer
Stephen M. Kane
Pro
Stephen M. Kane
5.0
Corporate Law lawyer
no photo
Pro
Eric H. Karp
4.6
Corporate Law lawyer
Joseph F. Ryan
Pro
Joseph F. Ryan
5.0
Corporate Law lawyer
Barry E. Gold
Pro
Barry E. Gold
5.0
Corporate Law lawyer
Case type is required.
I am is required.
First name is required.
Last name is required.
A valid zip code is required.
Country is required.
State is required.
A valid city is required.
A valid email address is required.
A valid phone number is required.
Message is required.
0/1000 characters

By clicking the Submit button, you agree to the Terms of Use, Supplemental Terms and Privacy Policy. You also consent to be contacted at the phone number you provided, including by autodials, text messages and/or pre-recorded calls, from Lawyers.com and its affiliates and from or on behalf of attorneys you request or contact through this site. Consent is not a condition of purchase.

You should not send any sensitive or confidential information through this site. Emails sent through this site do not create an attorney-client relationship and may not be treated as privileged or confidential. The lawyer or law firm you are contacting is not required to, and may choose not to, accept you as a client. The internet is not necessarily secure and emails sent though this site could be intercepted or read by third parties.

This site is protected by reCAPTCHA. See Google’s Privacy Policy and Terms of Service.

Thank you! Your message has been successfully sent.

For your records, a copy of this email has been sent to test@test.com.

Summary of Your Message
Case Type:
I am a/an:
First Name:
Last Name:
City:
Zip Code or Postal Code:
State:
Country:
Phone Number:
Message: